Raleigh Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
278
+55
| +25% | +$21.4K | 0.05% | 232 |
|
|
2025
Q1 | $97K | Sell |
223
-19
| -8% | -$8.27K | 0.04% | 233 |
|
|
2024
Q4 | $89.4K | Sell |
242
-17
| -7% | -$6.28K | 0.03% | 262 |
|
|
2024
Q3 | $134K | Sell |
259
-196
| -43% | -$102K | 0.05% | 233 |
|
|
2024
Q2 | $247K | Buy |
455
+222
| +95% | +$120K | 0.11% | 178 |
|
|
2024
Q1 | $121K | Buy |
233
+46
| +25% | +$23.8K | 0.05% | 231 |
|
|
2023
Q4 | $88.4K | Sell |
187
-487
| -72% | -$230K | 0.04% | 230 |
|
|
2023
Q3 | $293K | Buy |
674
+18
| +3% | +$7.83K | 0.15% | 135 |
|
|
2023
Q2 | $291K | Buy |
656
+64
| +11% | +$28.4K | 0.15% | 145 |
|
|
2023
Q1 | $272K | Buy |
592
+449
| +314% | +$206K | 0.13% | 149 |
|
|
2022
Q4 | $73.5K | Hold |
143
| – | – | 0.04% | 225 |
|
|
2022
Q3 | $65K | Hold |
143
| – | – | 0.04% | 223 |
|
|
2022
Q2 | $69K | Buy |
143
+1
| +0.7% | +$483 | 0.04% | 231 |
|
|
2022
Q1 | $70K | Buy |
+142
| New | +$70K | 0.04% | 238 |
|